Who is sponsoring NCT01369147?

NCT01369147 is sponsored by Emory University.

What condition does NCT01369147 study?

NCT01369147 studies Critical Illness.

What drugs are being tested in NCT01369147?

Interventions: Parenteral Nutrition, Propofol, Clevidipine, Dextrose-containing IV Fluids, Enteral feeding.

What is the status of NCT01369147?

NCT01369147 is currently TERMINATED.

Last reviewed 2022-05-18 · How we verify

Comparative Effectiveness of Energy Doses in Critical Illness

NCT01369147 Phase 2 TERMINATED Results posted

The investigators have designed this single-center Randomized Clinical Trial (RCT) to prospectively compare, for the first time, the clinical efficacy of different energy doses in intensive care unit (ICU) patients requiring parenteral nutrition (PN) due to intestinal failure/dysfunction. This study intends to enroll a total of 60 patients (20 per energy dose group) to generate critical preliminary data needed to inform subsequent appropriately powered Phase III multicenter trials.

Details

Lead sponsor	Emory University
Phase	Phase 2
Status	TERMINATED
Enrolment	12
Start date	2011-07
Completion	2014-12-02

Conditions

Critical Illness

Interventions

Parenteral Nutrition
Propofol
Clevidipine
Dextrose-containing IV Fluids
Enteral feeding

Primary outcomes

Number of Participants With Hospital-acquired Infection — Up to Day 28
The number of participants with a hospital-acquired infection during the study period is presented here.

Countries

United States